International Journal of Nanomedicine,
Год журнала:
2024,
Номер
Volume 19, С. 11445 - 11462
Опубликована: Ноя. 1, 2024
The
poor
delivery
and
limited
penetration
of
nanoparticles
into
breast
cancer
tumors
remain
essential
challenges
for
effective
anticancer
therapy.
This
study
aimed
to
design
a
promising
nanoplatform
with
efficient
tumor
targeting
capability
Advanced Healthcare Materials,
Год журнала:
2024,
Номер
unknown
Опубликована: Окт. 3, 2024
Abstract
Cold
exposure
(CE)
therapy
is
an
innovative
and
cost‐efficient
cancer
treatment
that
activates
brown
adipose
tissue
to
compete
for
glucose
uptake,
leading
metabolic
starvation
in
tumors.
Exploring
the
combined
antitumor
mechanisms
of
CE
traditional
therapies
(such
as
nanocatalysis)
exciting
promising.
In
this
study,
a
platelet
membrane
biomimetic
single‐atom
nanozyme
(SAEs)
nanodrug
(PFB)
carrying
bis‐2‐(5–phenylacetamido‐1,
2,
4‐thiadiazol‐2‐yl)
ethyl
sulfide
(BPTES)
developed
use
therapy.
Owing
modification,
PFB
can
effectively
target
Upon
entering
cells,
dual
effect
induced
by
BPTES
significantly
diminish
intracellular
ATP
levels,
resulting
substantial
reduction
cellular
(glutathione)
GSH,
which
enhance
cytotoxic
efficacy
reactive
oxygen
species
generated
SAEs.
This
strategy
not
only
boosts
ROS
production
tumors,
but
also
strengthens
immune
responses,
particularly
increasing
memory
T‐cell
abundance
suppressing
distant
tumor
growth
metastasis.
Compared
with
SAEs
alone,
approach
offers
superior
benefits
immunotherapy.
study
achieves
combination
nanomedicines
first
time,
providing
new
ideas
future
nanomedicine
modalities.
ACS Applied Nano Materials,
Год журнала:
2024,
Номер
7(3), С. 3445 - 3457
Опубликована: Янв. 26, 2024
Nanozymes
are
considered
promising
therapeutic
agents
for
infected
chronic
wounds
due
to
their
enzyme-like
activity-mediated
chemodynamic
therapy
(CDT).
However,
they
still
suffer
from
low
catalytic
efficiency
and
incapacity
address
excessive
glucose
heightened
inflammatory
responses
in
wounds.
Herein,
we
bound
Pd
sites
CeO2
nanosheets
atomically
dispersed
form
by
high-temperature
calcination,
followed
loading
oxidase
(GOx)
obtain
Pd–CeO2@GOx
single-atom
nanozymes
(SANZs)
enhanced
cascade
CDT
of
Specifically,
highly
endogenous
first
activates
the
activity
GOx
situ
self-supplement
H2O2
protons.
Then,
an
acidic
microenvironment,
single
atoms
exert
efficient
glutathione
peroxidase
(GSH-Px)
mimicking
amplify
(POD)-mimicking
activity,
generating
burst
•OH
eradicate
Gram-negative
Escherichia
coli
Gram-positive
Staphylococcus
aureus
pathogens
suppress
biofilm
formation.
Finally,
promote
catalase
(CAT)-mimicking
carriers
convert
remaining
O2,
which
relieves
contributes
blood
vessel
reconstruction
This
strategy
SANZs
could
accelerate
healing
within
17
days.
Therefore,
this
study
opens
up
insights
into
rational
design
multienzyme
active
Nano Biomedicine and Engineering,
Год журнала:
2023,
Номер
16(1), С. 1 - 27
Опубликована: Дек. 8, 2023
Single-atom
nanozymes
have
attracted
much
attention
as
a
new
type
of
high-performance
nanozymes.
Compared
with
other
nanozymes,
single-atom
become
the
most
promising
candidates
for
naturally-occurring
enzymes
due
to
their
lower
cost,
better
activity,
more
flexible
preparation,
higher
atom
utilization,
and
compositional
structural
modifications.
Moreover,
catalytic
activity
can
be
precisely
constructed
by
regulating
active
center
synergistic
environment.
Advanced
characterization
techniques
combined
theoretical
calculations
accurately
identify
enzyme-like
sites
deeply
reveal
structure-performance
correlation.
In
this
review,
activities
are
comprehensively
summarized
along
recent
research
advances
in
antitumor,
neurological
disorders,
wound
healing,
antimicrobial.
Finally,
we
also
explore
future
opportunities
challenges
design
applications.
ACS Applied Materials & Interfaces,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 8, 2025
Overcoming
tumor
antioxidant
defenses
remains
a
critical
challenge
for
reactive-oxygen-species-mediated
therapies.
To
address
this
problem,
herein,
theranostic
nanomedicine
designated
as
CCM@MIB
has
been
elaborately
constructed.
Homologous
cancer
cell
membrane
(CCM)
camouflage
significantly
enhances
the
selective
accumulation
of
at
sites.
In
response
to
microenvironment
(TME),
controllably
releases
Mn
ions
and
sulfur
dioxide
(SO2)
molecules.
The
released
catalyze
self-oxidation
isoniazid
generate
highly
toxic
•OH,
while
SO2
produced
by
benzothiazole
sulfinate
effectively
disrupts
defense
systems.
catalase-like
activity
endowed
increased
intracellular
•O2–
level
induced
further
promote
•OH
production.
Therefore,
such
an
intellectual
combination
non-Fenton-type
catalytic
therapy
gas
amplifies
oxidative
stress
efficiently
suppresses
growth.
Additionally,
TME-activated
magnetic
resonance
imaging
contrast
performance
is
beneficial
guiding
antitumor
treatment.
This
considerate
strategy
designed
in
our
work
provides
ingenious
paradigm
development
efficient
Biomaterials Science,
Год журнала:
2024,
Номер
12(9), С. 2341 - 2355
Опубликована: Янв. 1, 2024
Recently,
gas
therapy
has
emerged
as
a
promising
alternative
treatment
for
deep-seated
tumors.
However,
some
challenges
regarding
insufficient
or
uncontrolled
generation
well
unclear
therapeutic
mechanisms
restrict
its
further
clinical
application.
Herein,
well-designed
nanoreactor
based
on
intracellular
glutathione
(GSH)-triggered
of
sulfur
dioxide
(SO2)
to
augment
oxidative
stress
been
developed
synergistic
chemodynamic
(CDT)/sonodynamic
(SDT)/SO2
therapy.
The
(designed
CCM@FH-DNs)
is
constructed
by
employing
iron-doped
hollow
mesoporous
silica
nanoparticles
carriers,
the
surface
which
was
modified
with
SO2
prodrug
2,4-dinitrobenzenesulfonyl
(DNs)
and
coated
cancer
cell
membranes
homologous
targeting.
CCM@FH-DNs
can
not
only
serve
Fenton-like
agent
CDT,
but
also
sonosensitizer
SDT.
Importantly,
release
SO2-mediated
Both
in
vitro
vivo
evaluations
demonstrate
that
performs
augmenting
therapy-enhanced
CDT/SDT
via
GSH
depletion
peroxidase-4
enzyme
deactivation
superoxide
dismutase
inhibition.
Moreover,
doped
iron
ions
ensure
nanoreactors
enable
magnetic
resonance
imaging-guided
Such
GSH-triggered
strategy
provides
an
intelligent
paradigm
developing
efficient
tumor
microenvironment-responsive
treatments.